Acquires Option News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Acquires option. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Acquires Option Today - Breaking & Trending Today

MC2 Therapeutics Acquires Option to Phase 2 Oral Drug Candidate for Hidradenitis Suppurativa and Other Indications

MC2 Therapeutics Acquires Option to Phase 2 Oral Drug Candidate for Hidradenitis Suppurativa and Other IndicationsOption to exclusively license the rights to develop, manufacture and commercialize “RGRN-305” for all human indications, incl. oral treatment of Hidradenitis Suppurativa (“HS”)RGR. ....

Lars Iversen , Gautam Ghatnekar , Jesperj Lange , Hidradenitis Suppurativa , Venereology Congress , European Academy Of Dermatology , Aarhus University Hospital , Professor Of Dermatology At Aarhus University Hospital , Acquires Option , Drug Candidate , European Academy , Chair Professor ,